Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Fibroblast growth factor receptor 4 | ||
Ligand | BDBM50561591 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_2075295 (CHEMBL4730829) | ||
IC50 | 73±n/a nM | ||
Citation | Liu, H; Niu, D; Tham Sjin, RT; Dubrovskiy, A; Zhu, Z; McDonald, JJ; Fahnoe, K; Wang, Z; Munson, M; Scholte, A; Barrague, M; Fitzgerald, M; Liu, J; Kothe, M; Sun, F; Murtie, J; Ge, J; Rocnik, J; Harvey, D; Ospina, B; Perron, K; Zheng, G; Shehu, E; D'Agostino, LA Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular Carcinoma. ACS Med Chem Lett11:1899-1904 (2020) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Fibroblast growth factor receptor 4 | |||
Name: | Fibroblast growth factor receptor 4 | ||
Synonyms: | CD_antigen: CD334 FGFR4 | FGFR-4 | FGFR4 | FGFR4_HUMAN | Fibroblast growth factor receptor | Fibroblast growth factor receptor 4 (FGFR4) | JK2 | JTK2 | TKF | ||
Type: | Protein | ||
Mol. Mass.: | 87957.45 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P22455 | ||
Residue: | 802 | ||
Sequence: |
| ||
BDBM50561591 | |||
n/a | |||
Name | BDBM50561591 | ||
Synonyms: | CHEMBL4793510 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H25Cl2N5O4 | ||
Mol. Mass. | 518.392 | ||
SMILES | COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCC[C@@H]3NC(=O)C=C)nc2n(C)c1=O |r,wU:19.19,23.25,(19.41,-17.19,;18.08,-17.97,;18.08,-19.51,;19.42,-20.27,;19.43,-21.82,;20.76,-22.6,;20.77,-24.14,;18.09,-22.6,;18.09,-24.14,;16.75,-21.82,;16.75,-20.28,;15.42,-19.51,;15.42,-22.59,;14.09,-21.81,;12.77,-22.59,;11.45,-21.8,;10.11,-22.56,;10.1,-24.1,;8.76,-24.86,;7.43,-24.09,;7.28,-22.55,;5.77,-22.22,;5,-23.55,;6.02,-24.7,;5.69,-26.21,;4.22,-26.67,;3.08,-25.64,;3.89,-28.18,;2.42,-28.65,;11.42,-24.87,;12.75,-24.12,;14.09,-24.89,;14.08,-26.43,;15.43,-24.13,;16.76,-24.9,)| | ||
Structure |